# Duloxetine Delayed-Release

NDC: 68001-368
Generic name: DULOXETINE HYDROCHLORIDE
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, DELAYED RELEASE PELLETS
Routes: ORAL
Marketing started: 20180521

FDA application: ANDA203088

## Active ingredients

- DULOXETINE HYDROCHLORIDE: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-368"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-368
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a95cc04c-58e9-487f-8992-ef30df03a3cd